Larvol Delta - Cognition-Therapeutics-Study-of-Zervimesine-CT1812-in-Early-Alzheimers-Disease-Reaches-75-Enrollment-Target

Elayta (zervimesine) - Cognition Therap

https://www.globenewswire.com/news-release/2025/09/03/3143480/0/en/Cognition-Therapeutics-Study-of-Zervimesine-CT1812-in-Early-Alzheimer-s-Disease-Reaches-75-Enrollment-Target.html

Sep 3, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next